Impact of human bladder cancer cell architecture on autologous T‐lymphocyte activation
暂无分享,去创建一个
Pierre Validire | Guy Vallancien | S. Richon | P. Validire | D. Bellet | G. Vallancien | Dominique Bellet | Virginie Dangles | Mireille Wertheimer | Sophie Richon | Christophe Bovin | Dominique Zeliszewski | D. Zeliszewski | C. Bovin | V. Dangles | M. Wertheimer
[1] J. Armitage. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. , 1998, Blood.
[2] C. Viret,et al. LFA‐3 co‐stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR‐independent activation signal , 1998, European journal of immunology.
[3] P. Scardino,et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. , 1991, The New England journal of medicine.
[4] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[5] F. Marincola,et al. Melanoma vaccines: the paradox of T cell activation without clinical response , 2000, Cancer Chemotherapy and Pharmacology.
[6] A. Bergeron,et al. Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer , 1997, International journal of cancer.
[7] E. Parra,et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. , 1995, Critical reviews in immunology.
[8] M. Poupon,et al. Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. , 1997, Cancer research.
[9] E. Jaffee,et al. Cancer Vaccines , 1997, Current protocols in human genetics.
[10] S. Rosenberg,et al. Human tumor antigens for cancer vaccine development , 1999, Immunological reviews.
[11] C. Naus,et al. Radiation response of connexin43-transfected cells in relation to the "contact effect". , 1997, Experimental cell research.
[12] C. Y. Wang,et al. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. , 1996, Science.
[13] R. Knuechel,et al. Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.
[14] S. von Kleist,et al. Study of the resistance of tumor‐cell spheroids to penetration and lysis by activated effector cells , 1994, International journal of cancer.
[15] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.
[16] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[17] M. T. Santini,et al. Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids. , 1999, Anticancer research.
[18] B. Bodey,et al. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. , 2000, Anticancer research.
[19] M. Knapp,et al. Adaptation of EGF receptor signal transduction to three‐dimensional culture conditions: Changes in surface receptor expression and protein tyrosine phosphorylation , 1994, Journal of cellular physiology.
[20] V. Paradis,et al. MHC‐dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas , 1997, International journal of cancer.
[21] Maria Teresa Santini,et al. Three-Dimensional Spheroid Model in Tumor Biology , 1999, Pathobiology.
[22] S. Rosenberg,et al. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[23] T. Whiteside,et al. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] J. D. Young,et al. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. , 1987, Advances in immunology.
[25] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[26] T. Nederman. Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. , 1984, Cancer Research.
[27] S. Rosenberg,et al. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.